HHS appoints permanent FDA CBER, CDER heads - Pharmaceutical Technology

The HHS appoints these leadership positions as it looks to “reform” the FDA, which has recently faced a high turnover in leadership. The HHS sets out these permanent senior leadership positions as it looks to “reform” the FDA. These FDA appointment follow a tumultuous period for the agency, which was defined by several high-profile leadership changes. Credit: Tada Images / Shutterstock.com. The US Department of Health and Human Services (HHS) has selected four senior leaders to assume permanent positions in the US Food and Drug Administration (FDA), bringing some respite to a tumultuous period for the regulator fraught with several…

Source: Pharmaceutical Technology